Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 0 | 56,069 | 0 |
| Depreciation Amortization | 0 | 0 | 0 | 78,132 | 0 |
| Other Working Capital | 0 | 0 | 0 | 39,497 | 0 |
| Other Operating Activity | 0 | 0 | 0 | -11,079 | 0 |
| Operating Cash Flow | $0 | $0 | $0 | $162,619 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -116,070 | 0 |
| Net Acquisitions | 0 | 0 | 0 | 31,130 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -11,228 | 0 |
| Investing Cash Flow | $0 | $0 | $0 | $-96,168 | $0 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | 0 | -11,549 | 0 |
| Other Financing Activity | 0 | 0 | 0 | -91 | 0 |
| Financing Cash Flow | $0 | $0 | $0 | $-11,640 | $0 |
| Exchange Rate Effect | 0 | 0 | 0 | -602 | 0 |
| Beginning Cash Position | 0 | 0 | 0 | 43,509 | 0 |
| End Cash Position | 0 | 0 | 0 | 97,718 | 0 |
| Net Cash Flow | $0 | $0 | $0 | $54,209 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 0 | 162,619 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 162,619 | 0 |